Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Go Wish Game

Research Leaders

8 sponsors active, led by IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Completed3
Recruiting2
Not Yet Recruiting2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07852377Not ApplicableNot Yet Recruiting

Immunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple Myeloma

NCT07611812CompletedPrimary

Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review

NCT06795815Not ApplicableRecruiting

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

NCT07564128Not Yet RecruitingPrimary

Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy

NCT06874530RecruitingPrimary

Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+

NCT06810115CompletedPrimary

Respiatory Viral Infections in Patients With Multiple Myeloma

NCT06782854Completed

Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy

NCT01325896Phase 2UnknownPrimary

Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)

Showing all 8 trials

Research Network

Common Treatments

  • Go Wish Game1
  • Biological Sample Collection And Immunomonitoring1
  • Viral Pcr Test1
  • Pegintron Sc Injection1

Active Sponsors

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna2
  • University Medical Centre Ljubljana1
  • Fondazione IRCCS Policlinico San Matteo di Pavia1
  • Azienda USL Reggio Emilia - IRCCS1
  • Haematology Service,1

Top Investigators

Related Conditions

  • Oncology1
  • Chronic Lymphocytic Leukemia1
  • Hematologic Diseases1
  • Follicular Lymphoma1
  • Lymphoma1

Activity Timeline